[(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C59H103NO5 — CID 164504276

IUPAC[(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate
SMILESCC/C=C/C=C/C=C\C=C/CCCCCC(=O)OC(CCCCC/C=C/C=C/C=C/CCCCCCC)CC(=O)NC(CO)C(O)CCCCCCCCCCCCCCCCCCC
InChIInChI=1S/C59H103NO5/c1-4-7-10-13-16-19-22-25-27-29-31-34-36-39-42-45-48-51-57(62)56(54-61)60-58(63)53-55(50-47-44-41-38-35-33-30-28-26-23-20-17-14-11-8-5-2)65-59(64)52-49-46-43-40-37-32-24-21-18-15-12-9-6-3/h9,12,15,18,21,23-24,26,28,30,32-33,35,37,55-57,61-62H,4-8,10-11,13-14,16-17,19-20,22,25,27,29,31,34,36,38-54H2,1-3H3,(H,60,63)/b12-9+,18-15+,24-21-,26-23+,30-28+,35-33+,37-32-
InChIKeyZNSAOCAJNXXPFS-MUSRSZLOSA-N
MW906.47 g/mol
LogP16.73
Rot. Bonds48

About [(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate

[(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate (PubChem CID 164504276) has the molecular formula C59H103NO5 and a molecular weight of 906.47 g/mol. Its IUPAC name is [(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate.

Molecular Properties

Compound Name[(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate
PubChem CID164504276
Molecular FormulaC59H103NO5
Molecular Weight906.47 g/mol
Exact Mass905.78
IUPAC Name[(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate
SMILESCC/C=C/C=C/C=C\C=C/CCCCCC(=O)OC(CCCCC/C=C/C=C/C=C/CCCCCCC)CC(=O)NC(CO)C(O)CCCCCCCCCCCCCCCCCCC
InChIInChI=1S/C59H103NO5/c1-4-7-10-13-16-19-22-25-27-29-31-34-36-39-42-45-48-51-57(62)56(54-61)60-58(63)53-55(50-47-44-41-38-35-33-30-28-26-23-20-17-14-11-8-5-2)65-59(64)52-49-46-43-40-37-32-24-21-18-15-12-9-6-3/h9,12,15,18,21,23-24,26,28,30,32-33,35,37,55-57,61-62H,4-8,10-11,13-14,16-17,19-20,22,25,27,29,31,34,36,38-54H2,1-3H3,(H,60,63)/b12-9+,18-15+,24-21-,26-23+,30-28+,35-33+,37-32-
InChIKeyZNSAOCAJNXXPFS-MUSRSZLOSA-N
XLogP16.73
TPSA95.86 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds48
Heavy Atoms65
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500906.47
LogP ≤ 516.73
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze [(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate?
The IUPAC name of [(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate (CID 164504276) is [(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate.
What is the SMILES notation for [(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate?
The canonical SMILES for [(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate is CC/C=C/C=C/C=C\C=C/CCCCCC(=O)OC(CCCCC/C=C/C=C/C=C/CCCCCCC)CC(=O)NC(CO)C(O)CCCCCCCCCCCCCCCCCCC.
What is the InChIKey of [(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate?
The InChIKey is ZNSAOCAJNXXPFS-MUSRSZLOSA-N. The full InChI is InChI=1S/C59H103NO5/c1-4-7-10-13-16-19-22-25-27-29-31-34-36-39-42-45-48-51-57(62)56(54-61)60-58(63)53-55(50-47-44-41-38-35-33-30-28-26-23-20-17-14-11-8-5-2)65-59(64)52-49-46-43-40-37-32-24-21-18-15-12-9-6-3/h9,12,15,18,21,23-24,26,28,30,32-33,35,37,55-57,61-62H,4-8,10-11,13-14,16-17,19-20,22,25,27,29,31,34,36,38-54H2,1-3H3,(H,60,63)/b12-9+,18-15+,24-21-,26-23+,30-28+,35-33+,37-32-.
What are the key properties of [(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate?
[(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate has a molecular weight of 906.47 g/mol, XLogP of 16.73, 48 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(9E,11E,13E)-1-(1,3-dihydroxydocosan-2-ylamino)-1-oxohenicosa-9,11,13-trien-3-yl] (7Z,9Z,11E,13E)-hexadeca-7,9,11,13-tetraenoate is sourced from PubChem (CID 164504276), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).